16-81036066-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_015251.3(ATMIN):c.196G>A(p.Gly66Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000919 in 1,305,962 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_015251.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ATMIN | NM_015251.3 | c.196G>A | p.Gly66Arg | missense_variant | 1/4 | ENST00000299575.5 | |
CENPN-AS1 | XR_007065133.1 | n.87-1140C>T | intron_variant, non_coding_transcript_variant | ||||
CENPN-AS1 | XR_007065134.1 | n.3575+671C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ATMIN | ENST00000299575.5 | c.196G>A | p.Gly66Arg | missense_variant | 1/4 | 1 | NM_015251.3 | P1 | |
ATMIN | ENST00000562969.1 | n.9G>A | non_coding_transcript_exon_variant | 1/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000202 AC: 3AN: 148640Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000778 AC: 9AN: 1157322Hom.: 0 Cov.: 31 AF XY: 0.00000886 AC XY: 5AN XY: 564138
GnomAD4 genome AF: 0.0000202 AC: 3AN: 148640Hom.: 0 Cov.: 32 AF XY: 0.0000276 AC XY: 2AN XY: 72432
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 16, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at